Home » Stocks » VolitionRX

VolitionRX Limited (VNRX)

Stock Price: $3.04 USD -0.22 (-6.75%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 145.68M
Revenue (ttm) 22,834
Net Income (ttm) -18.63M
Shares Out 47.92M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $3.04
Previous Close $3.26
Change ($) -0.22
Change (%) -6.75%
Day's Open 3.16
Day's Range 3.02 - 3.24
Day's Volume 206,369
52-Week Range 2.22 - 6.12

More Stats

Market Cap 145.68M
Enterprise Value 127.86M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 47.92M
Float 29.72M
EPS (basic) -0.44
EPS (diluted) -0.45
FCF / Share -0.38
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.33M
Short Ratio 8.07
Short % of Float 4.48%
Beta 1.80
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6,379.87
PB Ratio 8.31
Revenue 22,834
Operating Income -18.99M
Net Income -18.63M
Free Cash Flow -16.42M
Net Cash 17.82M
Net Cash / Share 0.37
Gross Margin 74.87%
Operating Margin -83,145.34%
Profit Margin -81,567.80%
FCF Margin -71,900.09%
ROA -48.31%
ROE -106.38%
ROIC -504.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$7.14*
(134.87% upside)
Low
6.00
Current: $3.04
High
8.00
Target: 7.14
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.02------0.05--
Gross Profit0.02------0.05--
Operating Income-16.04-17.90-14.70-12.43-10.01-5.95-4.58-4.08-2.61-0.01
Net Income-16.10-18.01-14.77-11.91-9.53-8.21-3.71-4.08-2.61-0.01
Shares Outstanding39.1831.3926.3923.0517.7313.4410.839.365.772.29
Earnings Per Share-0.41-0.57-0.56-0.52-0.54-0.61-0.34-0.44-0.45-0.01
Operating Cash Flow-12.74-14.73-12.19-8.86-8.55-4.14-3.08-2.31-1.65-
Capital Expenditures-0.51-0.30-1.43-0.42-0.08-0.30--0.09-0.03-
Free Cash Flow-13.25-15.03-13.62-9.28-8.62-4.44-3.08-2.41-1.69-
Cash & Equivalents16.9713.4310.1221.685.922.140.890.380.350.00
Total Debt3.943.272.771.470.38--0.050.160.02
Net Cash / Debt13.0310.167.3520.215.532.140.890.320.19-0.02
Assets21.2917.4914.6224.737.713.432.072.222.25-
Liabilities7.095.354.673.561.673.061.391.381.160.11
Book Value14.2012.149.9621.186.040.370.680.831.09-0.11
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name VolitionRX Limited
Country United States
Employees 50
CEO Cameron John Reynolds

Stock Information

Ticker Symbol VNRX
Stock Exchange NYSE American
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSEAMERICAN: VNRX

Description

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRx Limited is headquartered in Austin, Texas.